Disc Medicine Inc (IRON)
46.27
+7.11
(+18.16%)
USD |
NASDAQ |
Jun 14, 16:00
46.23
-0.04
(-0.09%)
After-Hours: 20:00
Disc Medicine Enterprise Value: 801.26M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 801.26M |
| June 13, 2024 | 625.49M |
| June 12, 2024 | 617.82M |
| June 11, 2024 | 624.75M |
| June 10, 2024 | 639.33M |
| June 07, 2024 | 624.50M |
| June 06, 2024 | 558.74M |
| June 05, 2024 | 595.57M |
| June 04, 2024 | 561.46M |
| June 03, 2024 | 553.79M |
| May 31, 2024 | 496.69M |
| May 30, 2024 | 513.50M |
| May 29, 2024 | 501.38M |
| May 28, 2024 | 514.24M |
| May 24, 2024 | 504.84M |
| May 23, 2024 | 481.85M |
| May 22, 2024 | 477.40M |
| May 21, 2024 | 430.19M |
| May 20, 2024 | 457.63M |
| May 17, 2024 | 452.93M |
| May 16, 2024 | 446.50M |
| May 15, 2024 | 445.02M |
| May 14, 2024 | 444.52M |
| May 13, 2024 | 424.00M |
| May 10, 2024 | 407.94M |
| Date | Value |
|---|---|
| May 09, 2024 | 418.07M |
| May 08, 2024 | 382.72M |
| May 07, 2024 | 400.02M |
| May 06, 2024 | 403.24M |
| May 03, 2024 | 393.84M |
| May 02, 2024 | 374.31M |
| May 01, 2024 | 362.69M |
| April 30, 2024 | 345.63M |
| April 29, 2024 | 356.76M |
| April 26, 2024 | 338.46M |
| April 25, 2024 | 313.00M |
| April 24, 2024 | 332.28M |
| April 23, 2024 | 324.87M |
| April 22, 2024 | 324.37M |
| April 19, 2024 | 366.64M |
| April 18, 2024 | 399.52M |
| April 17, 2024 | 405.95M |
| April 16, 2024 | 397.30M |
| April 15, 2024 | 411.89M |
| April 12, 2024 | 443.46M |
| April 11, 2024 | 448.64M |
| April 10, 2024 | 435.80M |
| April 09, 2024 | 449.63M |
| April 08, 2024 | 442.22M |
| April 05, 2024 | 400.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-62.17M
Minimum
May 26 2022
1.499B
Maximum
Mar 01 2024
320.46M
Average
182.66M
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals Inc | 1.993B |
| Alnylam Pharmaceuticals Inc | 18.94B |
| Marinus Pharmaceuticals Inc | 40.70M |
| Rocket Pharmaceuticals Inc | 1.654B |
| Regenxbio Inc | 272.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.95M |
| Total Expenses (Quarterly) | 31.46M |
| EPS Diluted (Quarterly) | -1.09 |
| Earnings Yield | -7.30% |